Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BANX vs ABSI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BANX Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)

BANX Overall Winner 6-Pillar Tally: BANX 6 – 0 ABSI Matrix Metrics: BANX 7 – 3 ABSI

As of Nov 20, 2026, ArrowMark Financial Corp. (BANX) is the stronger overall head-to-head candidate over Absci Corporation (ABSI) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BANX carries a Unified Composite Score of 39.5/100 (SELL) at $18.79 (14.6x Forward P/E, 75.4% operating margin), whereas ABSI carries 61.0/100 (BUY) at $7.51 (N/M Forward P/E, -9108.3% operating margin).

  • Composite vs. Pillar Nuance: While ABSI currently prints a higher short-term Unified Composite Score (61.0/100 BUY vs. BANX 39.5/100 SELL), BANX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (75.4% vs. -9108.3% operating margin) and revenue trajectory (-0.2% vs. -19.6% YoY).
  • Technical & Structure Timing Caution: BANX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.4); meanwhile ABSI is in a Breakdown options structure phase (RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BANX vs ABSI
BANX NASDAQ Head-to-Head Winner
ArrowMark Financial Corp. Common Stock
Institutional Equity
$18.79
-0.74% 1D
Market Cap $183.4M
TTM Revenue $27M
Forward P/E 14.6x
Beta / 30D Vol 0.19β · 12% Vol
Unified Composite Score
39.5 / 100 SELL
Tech 28.0 Fund 46.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -2.5%), weak momentum, RSI 29
RSI-14: 29.4 · SMA20: $19.50 · SMA50: $19.93
ABSI NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.51
-7.97% 1D
Market Cap $1.4B
TTM Revenue $1.5M
Forward P/E N/M
Beta / 30D Vol 3.18β · 122% Vol
Unified Composite Score
61.0 / 100 BUY
Tech 75.0 Fund 63.0 Flow 57.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 39
RSI-14: 39.2 · SMA20: $9.61 · SMA50: $9.58

6-Pillar Scorecard Institutional Category Breakdown (BANX 6 – 0 ABSI)

Columns: Metric · BANX · ABSI
1. Valuation Multiples BANX
Forward P/E 14.6x N/M
Trailing P/E 17.7x N/M
PEG Ratio N/M N/M
EV / Revenue 6.9x N/M
2. Growth & Scale BANX
Revenue Growth (YoY) -0.2% -19.6%
Earnings Growth (YoY) -58.1% +0.0%
TTM Revenue (USD) $27M $1.5M
Market Cap $183.4M $1.4B
3. Profitability & Quality BANX
Gross Margin 100.0% N/A
Operating Margin 75.4% -9108.3%
Net Profit Margin 50.8% 0.0%
Return on Equity (ROE) 7.4% -58.6%
4. Balance Sheet & Cash Flow BANX
Cash Generation (TTM) N/A -$112M
Cash Flow Margin N/A N/A
Net Cash / Leverage $21.00 Book/Sh · 7.4% ROE $10M Net Cash
Dividend Yield 9.33% None (0.00%)
5. Options & Positioning BANX
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile 80.3% (14th %ile) 108.5% (7th %ile)
Put/Call OI Skew N/A 0.80x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat BANX
OpEx & R&D Intensity 24.6% of Rev ($6.5M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Asset Management Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BANX (7) vs ABSI (3)
Institutional Metric BANX ABSI Criterion Row Edge
Market Capitalization
Scale
$183.4M $1.4B Larger Scale ABSI
Trailing P/E Ratio
Valuation
17.7x N/M Lower Multiple BANX
Forward P/E Ratio
Valuation
14.6x N/M Lower Multiple BANX
Revenue Growth (YoY)
Growth
-0.2% -19.6% Higher Growth BANX
Operating Margin (TTM)
Profitability
75.4% -9108.3% Higher Margin BANX
Net Profit Margin
Profitability
50.8% 0.0% Higher Margin BANX
Return on Equity (ROE)
Capital Efficiency
7.4% -58.6% Higher ROE BANX
52-Week Range Position
Momentum
8% ($18–$22) 51% ($2–$13) Stronger Trend ABSI
Beta / 30D Volatility
Risk Regime
0.19β · 12% Vol 3.18β · 122% Vol Lower Realized Risk BANX
Unified Institutional Score
Composite Signal
39.5 / 100 (SELL) 61.0 / 100 (BUY) Higher Composite ABSI
Trailing 12M Revenue (USD)
Operating Scale
$27M $1.5M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 6.9x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($21.00 Book/Sh · 7.4% ROE) -$112M ($10M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BANX +13.75 pp
BANX: -6.1% · ABSI: -19.85%
3M Horizon BANX +5.98 pp
BANX: -9.07% · ABSI: -15.05%
6M Horizon ABSI +51.82 pp
BANX: -4.57% · ABSI: +47.25%
1Y Horizon ABSI +173.75 pp
BANX: -11.16% · ABSI: +162.59%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BANX vs ABSI. Trailing 12-month operating profitability (BANX 75.4% vs ABSI -9108.3%) and valuation multiples (BANX 14.6x vs ABSI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BANX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$27M
Gross Margin100.0%
Op. Margin75.4%
ROE / Fwd P/E7.4% · 14.6x
ABSI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.5M
Gross MarginN/A
Op. Margin-9108.3%
ROE / Fwd P/E-58.6% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BANX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 80.3%
IV Percentile 14th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BANX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABSI BREAKDOWN
101d in phase · OBV DISTRIBUTION
Current IV 108.5%
IV Percentile 7th %ile
Put/Call OI Skew 0.80x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact ABSI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BANX Moat Profile High-Margin Pricing Power Moat
Asset Management Operator
Competes within the Asset Management value chain with $183.4M market capitalization and 75.4% operating margin.
OpEx & R&D Reinvestment 24.6% of Rev ($6.5M)
90D Engineering Disclosures 0 Published
ABSI Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.4B market capitalization and -9108.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BANX vs ABSI Key Questions & Quantitative Answers

As of Nov 20, 2026, ArrowMark Financial Corp. (BANX) is the stronger overall head-to-head candidate over Absci Corporation (ABSI) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BANX carries a Unified Composite Score of 39.5/100 (SELL) at $18.79 (14.6x Forward P/E, 75.4% operating margin), whereas ABSI carries 61.0/100 (BUY) at $7.51 (N/M Forward P/E, -9108.3% operating margin). Composite vs. Pillar Nuance: While ABSI currently prints a higher short-term Unified Composite Score (61.0/100 BUY vs. BANX 39.5/100 SELL), BANX captures the overall institutional head-to-head verdict (7–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (75.4% vs. -9108.3% operating margin) and revenue trajectory (-0.2% vs. -19.6% YoY). Technical & Structure Timing Caution: BANX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 29.4); meanwhile ABSI is in a Breakdown options structure phase (RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BANX leads the Growth & Scale pillar: BANX posts -0.2% YoY revenue growth and -58.1% YoY earnings growth on $27M TTM revenue (100.0% gross margin, 75.4% operating margin), compared with ABSI at -19.6% YoY revenue growth and +0.0% YoY earnings growth on $1.5M TTM revenue (N/A gross margin, -9108.3% operating margin). On trailing 12-month operating scale, BANX generates $27M in USD-normalized revenue versus $1.5M for ABSI. In operating R&D and SG&A reinvestment, BANX deploys 24.6% of Rev ($6.5M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ABSI.

BANX screens cheaper on headline valuation multiples. BANX trades at 14.6x Forward P/E, 17.7x Trailing P/E, N/M PEG, and 6.9x EV/Revenue (unreported cash flow margin), whereas ABSI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BANX (7.4% ROE) versus ABSI (-58.6% ROE) capital efficiency.

In options market volatility and institutional positioning, BANX carries 80.3% implied volatility (14th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 12% Vol realized risk). By comparison, ABSI carries 108.5% implied volatility (7th %ile, Compressed (<25th %ile)), a 0.80x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.18β · 122% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.